Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

Blood-borne and sexually transmitted infections: a cross-sectional study in a Swiss prison

Authors: Komal Chacowry Pala, Stéphanie Baggio, Nguyen Toan Tran, François Girardin, Hans Wolff, Laurent Gétaz

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

Incarcerated people carry a high burden of infection, including blood-borne diseases (BBDs). It is also known that one million people contract a sexually transmitted infection (STI) every day worldwide, which represents a global public health challenge. However, data regarding the prevalence of STIs and the risk factors among incarcerated populations are lacking. The objective of this study was to determine the prevalence and associated factors of BBDs and STIs among detainees in the largest pre-trial prison in Switzerland.

Methods

In a cross-sectional study conducted at the Champ-Dollon pre-trial prison, 273 male detainees answered a standardized questionnaire and were screened for syphilis, herpes simplex virus 2 (HSV-2), HIV, and hepatitis C (HCV). Prevalence rates and associations of BBDs and STIs with risk factors were computed.

Results

Most participants (90.9%) were migrants from outside Western Europe, and 5.9% were injecting drug users. HCV was diagnosed among 6.2% of participants (antibody prevalence). The prevalence of HCV was higher among injecting drug users (81.2%) than non-injectors (1.6%). The prevalence of HIV, syphilis, and HSV-2 was 0.4%, 1.1%, and 22.4%, respectively. HCV was associated with a history of injecting drug use and HSV-2 with a lower education level and being older than 26 years.

Conclusions

This study showed the infection prevalence of 2–9 times higher among detainees than in the Swiss community. It also illustrated that these infections are associated with sociodemographic and risk factors. Therefore, the prison environment offers an opportunity to strengthen infectious disease control programs targeting specific subgroups of at-risk people. Such programs would benefit both the prison population and broader society.
Literature
1.
go back to reference Hammett TM. HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response. Am J Public Health. 2006;96(6):974–8.CrossRef Hammett TM. HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response. Am J Public Health. 2006;96(6):974–8.CrossRef
2.
go back to reference Negro F. Epidemiology of hepatitis C in Europe. Dig Liver Dis. 2014;46(Supplement 5):S158–64.CrossRef Negro F. Epidemiology of hepatitis C in Europe. Dig Liver Dis. 2014;46(Supplement 5):S158–64.CrossRef
3.
go back to reference Felisberto M, Saretto AA, Wopereis S, Treitinger A, Machado MJ, Spada C. Prevalence of human immunodeficiency virus infection and associated risk factors among prison inmates in the City of Florianópolis. Rev Soc Bras Med Trop. 2016;49(5):620–3.CrossRef Felisberto M, Saretto AA, Wopereis S, Treitinger A, Machado MJ, Spada C. Prevalence of human immunodeficiency virus infection and associated risk factors among prison inmates in the City of Florianópolis. Rev Soc Bras Med Trop. 2016;49(5):620–3.CrossRef
4.
go back to reference Fakoya I, Álvarez-del Arco D, Woode-Owusu M, Monge S, Rivero-Montesdeoca Y, Delpech V, Rice B, Noori T, Pharris A, Amato-Gauci AJ, et al. A systematic review of post-migration acquisition of HIV among migrants from countries with generalised HIV epidemics living in Europe: mplications for effectively managing HIV prevention programmes and policy. BMC Public Health. 2015;15:561.CrossRef Fakoya I, Álvarez-del Arco D, Woode-Owusu M, Monge S, Rivero-Montesdeoca Y, Delpech V, Rice B, Noori T, Pharris A, Amato-Gauci AJ, et al. A systematic review of post-migration acquisition of HIV among migrants from countries with generalised HIV epidemics living in Europe: mplications for effectively managing HIV prevention programmes and policy. BMC Public Health. 2015;15:561.CrossRef
5.
go back to reference Carmona-Gutierrez D, Kainz K, Madeo F. Sexually transmitted infections: old foes on the rise. Microb Cell. 2016;3(9):361–2.CrossRef Carmona-Gutierrez D, Kainz K, Madeo F. Sexually transmitted infections: old foes on the rise. Microb Cell. 2016;3(9):361–2.CrossRef
6.
go back to reference Stamm LV. Syphilis: Re-emergence of an old foe. Microb Cell. 2016;3(9):363–70.CrossRef Stamm LV. Syphilis: Re-emergence of an old foe. Microb Cell. 2016;3(9):363–70.CrossRef
7.
go back to reference Looker KJ, Elmes JAR, Gottlieb SL, Schiffer JT, Vickerman P, Turner KME, Boily M-C. Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis. Lancet Infect Dis. 2017;17(12):1303–16.CrossRef Looker KJ, Elmes JAR, Gottlieb SL, Schiffer JT, Vickerman P, Turner KME, Boily M-C. Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis. Lancet Infect Dis. 2017;17(12):1303–16.CrossRef
8.
go back to reference Schiffer JT, Corey L. New concepts in understanding genital herpes. Curr Infect Dis Rep. 2009;11(6):457–64.CrossRef Schiffer JT, Corey L. New concepts in understanding genital herpes. Curr Infect Dis Rep. 2009;11(6):457–64.CrossRef
9.
go back to reference CDC: STD Facts - Syphilis (Detailed). In. Atlanta, USA: Centers for Disease Control and Prevention; 2017. CDC: STD Facts - Syphilis (Detailed). In. Atlanta, USA: Centers for Disease Control and Prevention; 2017.
10.
go back to reference Marques NMS, Margalho R, Melo MJ, da Cunha JGS, Meliço-Silvestre AA. Seroepidemiological survey of transmissible infectious diseases in a Portuguese prison establishment. Braz J Infect Dis. 2011;15(3):272–5.PubMed Marques NMS, Margalho R, Melo MJ, da Cunha JGS, Meliço-Silvestre AA. Seroepidemiological survey of transmissible infectious diseases in a Portuguese prison establishment. Braz J Infect Dis. 2011;15(3):272–5.PubMed
11.
go back to reference Scott JA, Chew KW. Treatment optimization for HIV/HCV co-infected patients. Ther Adv Infect Dis. 2017;4(1):18–36.PubMed Scott JA, Chew KW. Treatment optimization for HIV/HCV co-infected patients. Ther Adv Infect Dis. 2017;4(1):18–36.PubMed
12.
go back to reference Dolan K, Wirtz AL, Moazen B, Ndeffo-Mbah M, Galvani A, Kinner SA, Courtney R, McKee M, Amon JJ, Maher L, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet (London, England). 2016;388(10049):1089–102.CrossRef Dolan K, Wirtz AL, Moazen B, Ndeffo-Mbah M, Galvani A, Kinner SA, Courtney R, McKee M, Amon JJ, Maher L, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet (London, England). 2016;388(10049):1089–102.CrossRef
13.
go back to reference UNAIDS: The gap report 2014. In. Geneva, Switzerland: The gap report 2014; 2014. UNAIDS: The gap report 2014. In. Geneva, Switzerland: The gap report 2014; 2014.
14.
go back to reference Kouyoumdjian FG, Leto D, John S, Henein H, Bondy S. A systematic review and meta-analysis of the prevalence of chlamydia, gonorrhoea and syphilis in incarcerated persons. Int J STD AIDS. 2012;23(4):248–54.CrossRef Kouyoumdjian FG, Leto D, John S, Henein H, Bondy S. A systematic review and meta-analysis of the prevalence of chlamydia, gonorrhoea and syphilis in incarcerated persons. Int J STD AIDS. 2012;23(4):248–54.CrossRef
15.
go back to reference Office SFS: Swiss statistics - prisons, detention - key figures. In.: Swiss federal statistical Office; 2011. Office SFS: Swiss statistics - prisons, detention - key figures. In.: Swiss federal statistical Office; 2011.
16.
go back to reference Rieder JP, Bertrand D, Wolff H, Gravier B, Pasche C, Bodenmann P. Santé en milieu pénitentiaire : vulnérabilité partagée entre détenus et professionnels de la santé. Rev Méd Suisse. 2010;6:1462–5.PubMed Rieder JP, Bertrand D, Wolff H, Gravier B, Pasche C, Bodenmann P. Santé en milieu pénitentiaire : vulnérabilité partagée entre détenus et professionnels de la santé. Rev Méd Suisse. 2010;6:1462–5.PubMed
17.
go back to reference Baggio S, Gétaz L, Tran NT, Peigné N, Chacowry Pala K, Golay D, Heller P, Bodenmann P, Wolff H. Association of overcrowding and turnover with self-harm in a Swiss pre-trial prison. Int J Environ Res Public Health. 2018;15(4):1-6.CrossRef Baggio S, Gétaz L, Tran NT, Peigné N, Chacowry Pala K, Golay D, Heller P, Bodenmann P, Wolff H. Association of overcrowding and turnover with self-harm in a Swiss pre-trial prison. Int J Environ Res Public Health. 2018;15(4):1-6.CrossRef
18.
go back to reference Wolff H, Sebo P, Haller DM, Eytan A, Niveau G, Bertrand D, Gétaz L, Cerutti B. Health problems among detainees in Switzerland: a study using the ICPC-2 classification. BMC Public Health. 2011;11:245.CrossRef Wolff H, Sebo P, Haller DM, Eytan A, Niveau G, Bertrand D, Gétaz L, Cerutti B. Health problems among detainees in Switzerland: a study using the ICPC-2 classification. BMC Public Health. 2011;11:245.CrossRef
19.
go back to reference Barro J, Casillas A, Gétaz L, Rieder J-P, Baroudi M, François A, Broers B, Wolff H. Retractable syringes in a Swiss prison needle and syringe exchange program: experiences of drug-using inmates and prison staff perceptions. Int J Ment Health Addiction. 2014;12(5):648–59.CrossRef Barro J, Casillas A, Gétaz L, Rieder J-P, Baroudi M, François A, Broers B, Wolff H. Retractable syringes in a Swiss prison needle and syringe exchange program: experiences of drug-using inmates and prison staff perceptions. Int J Ment Health Addiction. 2014;12(5):648–59.CrossRef
20.
go back to reference Favrod-Coune T, Baroudi M, Casillas A, Rieder J-P, Gétaz L, Barro J, Gaspoz J-M, Broers B, Wolff H. Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland. Swiss Med Wkly. 2013;143:w13898.PubMed Favrod-Coune T, Baroudi M, Casillas A, Rieder J-P, Gétaz L, Barro J, Gaspoz J-M, Broers B, Wolff H. Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland. Swiss Med Wkly. 2013;143:w13898.PubMed
21.
go back to reference Gétaz L, Casillas A, Siegrist C-A, Chappuis F, Togni G, Tran NT, Baggio S, Negro F, Gaspoz J-M, Wolff H. Hepatitis B prevalence, risk factors, infection awareness and disease knowledge among inmates: a cross-sectional study in Switzerland’s largest pre-trial prison. J Glob Health. 2018;8(2):020407 Accepted.CrossRef Gétaz L, Casillas A, Siegrist C-A, Chappuis F, Togni G, Tran NT, Baggio S, Negro F, Gaspoz J-M, Wolff H. Hepatitis B prevalence, risk factors, infection awareness and disease knowledge among inmates: a cross-sectional study in Switzerland’s largest pre-trial prison. J Glob Health. 2018;8(2):020407 Accepted.CrossRef
22.
go back to reference Kohler P, Schmidt AJ, Cavassini M, Furrer H, Calmy A, Battegay M, Bernasconi E, Ledergerber B, Vernazza P, Swiss HIVCS. The HIV care cascade in Switzerland: reaching the UNAIDS/WHO targets for patients diagnosed with HIV. AIDS. 2015;29(18):2509–15.CrossRef Kohler P, Schmidt AJ, Cavassini M, Furrer H, Calmy A, Battegay M, Bernasconi E, Ledergerber B, Vernazza P, Swiss HIVCS. The HIV care cascade in Switzerland: reaching the UNAIDS/WHO targets for patients diagnosed with HIV. AIDS. 2015;29(18):2509–15.CrossRef
23.
go back to reference Hellard ME, Aitken CK. HIV in prison: what are the risks and what can be done? Sex Health. 2004;1(2):107–13.CrossRef Hellard ME, Aitken CK. HIV in prison: what are the risks and what can be done? Sex Health. 2004;1(2):107–13.CrossRef
24.
go back to reference Sakem B, Madaliński K, Nydegger U, Stępień M, Godzik P, Kołakowska A, Risch L, Risch M, Zakrzewska K, Rosińska M. Hepatitis C virus epidemiology and prevention in polish and Swiss population - similar and contrasting experiences. Ann Agric Environ Med. 2016;23(3):425–31.CrossRef Sakem B, Madaliński K, Nydegger U, Stępień M, Godzik P, Kołakowska A, Risch L, Risch M, Zakrzewska K, Rosińska M. Hepatitis C virus epidemiology and prevention in polish and Swiss population - similar and contrasting experiences. Ann Agric Environ Med. 2016;23(3):425–31.CrossRef
25.
go back to reference Bünzli D, Wietlisbach V, Barazzoni F, Sahli R, Meylan PRA. Seroepidemiology of herpes simplex virus type 1 and 2 in Western and southern Switzerland in adults aged 25-74 in 1992-93: a population-based study. BMC Infect Dis. 2004;4:10.CrossRef Bünzli D, Wietlisbach V, Barazzoni F, Sahli R, Meylan PRA. Seroepidemiology of herpes simplex virus type 1 and 2 in Western and southern Switzerland in adults aged 25-74 in 1992-93: a population-based study. BMC Infect Dis. 2004;4:10.CrossRef
26.
go back to reference Sarmati L, Babudieri S, Longo B, Starnini G, Carbonara S, Monarca R, Buonomini AR, Dori L, Rezza G, Andreoni M, et al. Human herpesvirus 8 and human herpesvirus 2 infections in prison population. J Med Virol. 2007;79(2):167–73.CrossRef Sarmati L, Babudieri S, Longo B, Starnini G, Carbonara S, Monarca R, Buonomini AR, Dori L, Rezza G, Andreoni M, et al. Human herpesvirus 8 and human herpesvirus 2 infections in prison population. J Med Virol. 2007;79(2):167–73.CrossRef
27.
go back to reference Butler T, Donovan B, Taylor J, Cunningham AL, Mindel A, Levy M, Kaldor J. Herpes simplex virus type 2 in prisoners, New South Wales, Australia. Int J STD AIDS. 2000;11(11):743–7.CrossRef Butler T, Donovan B, Taylor J, Cunningham AL, Mindel A, Levy M, Kaldor J. Herpes simplex virus type 2 in prisoners, New South Wales, Australia. Int J STD AIDS. 2000;11(11):743–7.CrossRef
28.
go back to reference Newman L, Rowley J, Hoorn SV, Wijesooriya NS, Unemo M, Low N, Stevens G, Gottlieb S, Kiarie J, Temmerman M. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One. 2015;10(12):e0143304.CrossRef Newman L, Rowley J, Hoorn SV, Wijesooriya NS, Unemo M, Low N, Stevens G, Gottlieb S, Kiarie J, Temmerman M. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One. 2015;10(12):e0143304.CrossRef
29.
go back to reference Ficarra G, Carlos R. Syphilis: the renaissance of an old disease with oral implications. Head Neck Pathol. 2009;3(3):195–206.CrossRef Ficarra G, Carlos R. Syphilis: the renaissance of an old disease with oral implications. Head Neck Pathol. 2009;3(3):195–206.CrossRef
31.
go back to reference Vescio MF, Longo B, Babudieri S, Starnini G, Carbonara S, Rezza G, Monarca R. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. J Epidemiol Community Health. 2008;62(4):305–13.CrossRef Vescio MF, Longo B, Babudieri S, Starnini G, Carbonara S, Rezza G, Monarca R. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. J Epidemiol Community Health. 2008;62(4):305–13.CrossRef
32.
go back to reference Tan JA, Joseph TA, Saab S. Treating hepatitis C in the prison population is cost-saving. Hepatology. 2008;48(5):1387–95.CrossRef Tan JA, Joseph TA, Saab S. Treating hepatitis C in the prison population is cost-saving. Hepatology. 2008;48(5):1387–95.CrossRef
33.
go back to reference Wald A. Herpes simplex virus type 2 transmission: risk factors and virus shedding. Herpes. 2004;11(Suppl 3):130A–7A.PubMed Wald A. Herpes simplex virus type 2 transmission: risk factors and virus shedding. Herpes. 2004;11(Suppl 3):130A–7A.PubMed
34.
go back to reference Looker KJ, Magaret AS, May MT, Turner KME, Vickerman P, Gottlieb SL, Newman LM. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One. 2015;10(10):e0140765.CrossRef Looker KJ, Magaret AS, May MT, Turner KME, Vickerman P, Gottlieb SL, Newman LM. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One. 2015;10(10):e0140765.CrossRef
35.
go back to reference Jolivet R, Sahli R, Meylan PRA. Herpès génital : l’épidémie silencieuse ? Rev Méd Suisse. 2001;3:21258. Jolivet R, Sahli R, Meylan PRA. Herpès génital : l’épidémie silencieuse ? Rev Méd Suisse. 2001;3:21258.
36.
go back to reference Koelle DM, Wald A. Herpes simplex virus: the importance of asymptomatic shedding. J Antimicrob Chemother. 2000;45(Suppl T3):1–8.CrossRef Koelle DM, Wald A. Herpes simplex virus: the importance of asymptomatic shedding. J Antimicrob Chemother. 2000;45(Suppl T3):1–8.CrossRef
37.
go back to reference Moazen B, Saeedi Moghaddam S, Silbernagl MA, Lotfizadeh M, Bosworth RJ, Alammehrjerdi Z, Kinner SA, Wirtz AL, Bärnighausen TW, Stöver HJ, et al. Prevalence of drug injection, sexual activity, tattooing, and piercing among prison inmates. Epidemiol Rev. 2018;40(1):58–69.CrossRef Moazen B, Saeedi Moghaddam S, Silbernagl MA, Lotfizadeh M, Bosworth RJ, Alammehrjerdi Z, Kinner SA, Wirtz AL, Bärnighausen TW, Stöver HJ, et al. Prevalence of drug injection, sexual activity, tattooing, and piercing among prison inmates. Epidemiol Rev. 2018;40(1):58–69.CrossRef
38.
go back to reference Ndeffo-Mbah ML, Vigliotti VS, Skrip LA, Dolan K, Galvani AP. Dynamic models of infectious disease transmission in prisons and the general population. Epidemiol Rev. 2018;40(1):40–57.CrossRef Ndeffo-Mbah ML, Vigliotti VS, Skrip LA, Dolan K, Galvani AP. Dynamic models of infectious disease transmission in prisons and the general population. Epidemiol Rev. 2018;40(1):40–57.CrossRef
39.
go back to reference Rich JD, Beckwith CG, Macmadu A, Marshall BDL, Brinkley-Rubinstein L, Amon JJ, Milloy MJ, King MRF, Sanchez J, Atwoli L, et al. Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis. Lancet (London, England). 2016;388(10049):1103–14.CrossRef Rich JD, Beckwith CG, Macmadu A, Marshall BDL, Brinkley-Rubinstein L, Amon JJ, Milloy MJ, King MRF, Sanchez J, Atwoli L, et al. Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis. Lancet (London, England). 2016;388(10049):1103–14.CrossRef
40.
go back to reference Tran NT, Dubost C, Baggio S, Gétaz L, Wolff H. Safer tattooing interventions in prisons: a systematic review and call to action. BMC Public Health. 2018;18(1):1015.CrossRef Tran NT, Dubost C, Baggio S, Gétaz L, Wolff H. Safer tattooing interventions in prisons: a systematic review and call to action. BMC Public Health. 2018;18(1):1015.CrossRef
41.
go back to reference Tavoschi L, Vroling H, Madeddu G, Babudieri S, Monarca R, Vonk Noordegraaf-Schouten M, Beer N, Gomes Dias J, O'Moore É, Hedrich D, et al. Active case finding for communicable diseases in prison settings: increasing testing coverage and uptake among the prison population in the European Union/European economic area. Epidemiol Rev. 2018;40(1):105–20.CrossRef Tavoschi L, Vroling H, Madeddu G, Babudieri S, Monarca R, Vonk Noordegraaf-Schouten M, Beer N, Gomes Dias J, O'Moore É, Hedrich D, et al. Active case finding for communicable diseases in prison settings: increasing testing coverage and uptake among the prison population in the European Union/European economic area. Epidemiol Rev. 2018;40(1):105–20.CrossRef
42.
go back to reference Nokhodian Z, Yazdani MR, Yaran M, Shoaei P, Mirian M, Ataei B, Babak A, Ataie M. Prevalence and risk factors of HIV, syphilis, hepatitis B and C among female prisoners in Isfahan, Iran. Hepat Mon. 2012;12(7):442–7.CrossRef Nokhodian Z, Yazdani MR, Yaran M, Shoaei P, Mirian M, Ataei B, Babak A, Ataie M. Prevalence and risk factors of HIV, syphilis, hepatitis B and C among female prisoners in Isfahan, Iran. Hepat Mon. 2012;12(7):442–7.CrossRef
43.
go back to reference Kazi AM, Shah SA, Jenkins CA, Shepherd BE, Vermund SH. Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan. Int J Infect Dis. 2010;14(Suppl 3):e60–6.CrossRef Kazi AM, Shah SA, Jenkins CA, Shepherd BE, Vermund SH. Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan. Int J Infect Dis. 2010;14(Suppl 3):e60–6.CrossRef
Metadata
Title
Blood-borne and sexually transmitted infections: a cross-sectional study in a Swiss prison
Authors
Komal Chacowry Pala
Stéphanie Baggio
Nguyen Toan Tran
François Girardin
Hans Wolff
Laurent Gétaz
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3445-6

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue